DocGo Inc.

DocGo Inc.

DCGOW
DocGo Inc.US flagNASDAQ Global Market
1.96
USD
-0.06
- -
DocGo Inc.
DCGOW
(NASDAQ Global Market)

Recent

price

1.96

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
DocGo Inc. (NASDAQ:DCGOW) operates as a technology-enabled healthcare services platform that delivers mobile health services and medical transportation solutions, including on-demand doctor house calls, event medicine staffing, air and ground medical transport, and remote patient monitoring; its proprietary platform integrates telemedicine, dispatch logistics, and electronic health records to connect patients, providers, and payors. The company serves individual consumers, employers, insurers, health systems, and government entities across the United States and internationally, with operations primarily in North America and expanding into Europe. Founded in 2015 and headquartered in New York, New York, DocGo focuses on the mobile health and emergency medical services segments, offering services under brands such as DocGo Health and Motion Health. In recent developments, DocGo completed the acquisition of MobilityX Labs in early 2025 to bolster its autonomous vehicle technology for medical transport, enhancing operational efficiency; it also announced a strategic partnership with a major U.S. health insurer in Q3 2025 to expand telemedicine access in underserved regions; additionally, the company secured a $50 million funding round led by existing investors to fuel international growth and new remote monitoring product launches.